Depressive symptoms and elevated C-reactive protein levels are common among individuals with schizophrenia, but little is known about the relationship between these factors. In a recent study, researchers...
While higher lifetime antipsychotic exposure has been associated with poorer cognition in patients with schizophrenia, the effects of adjunctive psychiatric medication use and lifetime trends are not well...
In a recent study, researchers sought to determine whether routine testing of patients who presented to emergency departments with chest pain but without evidence of ischemia influenced admission rates for...
In a recent study, researchers compared the safety and efficacy of 2 drugs for adults with acute exacerbations of schizophrenia. To see results of the study, including which drugs were evaluated, read...
Schizophrenia patients taking antipsychotics face a greater risk of cardiovascular disease. In a recent study, researchers tested the effects of a glucagon-like peptide-1 receptor agonist in schizophrenia...
The findings of a recent study challenge the hypothesis that schizophrenia and other cognitive impairments are associated with GABA deficiency. The study compared the brain chemistry of schizophrenia...